Use of Pre-Emptive Donor Lymphocyte Infusions To Achieve Durable Remission Following Alemtuzumab Based Reduced Intensity Conditioning (RIC) Transplantation for AML or MDS.
- Resource Type
- Abstract
- Source
- In
Blood 16 November 2005 106(11):1124-1124 - Subject
- Language
- ISSN
- 0006-4971